NASDAQ:DOCS Doximity (DOCS) Stock Price, News & Analysis → The Key to this $10 Trillion Tech Boom (From Porter & Company) (Ad) Free DOCS Stock Alerts $29.25 -0.35 (-1.18%) (As of 10:10 AM ET) Add Compare Share Share Today's Range$29.25▼$29.7050-Day Range$23.00▼$29.8852-Week Range$19.71▼$36.29Volume131,880 shsAverage Volume1.74 million shsMarket Capitalization$5.42 billionP/E Ratio40.63Dividend YieldN/APrice Target$28.73 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Get Doximity alerts: Email Address Doximity MarketRank™ Stock AnalysisAnalyst RatingHold2.13 Rating ScoreUpside/Downside2.9% Downside$28.73 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.21Based on 21 Articles This WeekInsider TradingSelling Shares$171,250 Sold Last QuarterProj. Earnings Growth10.81%From $0.74 to $0.82 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.34 out of 5 starsMedical Sector509th out of 917 stocksCustom Computer Programming Services Industry12th out of 24 stocks 2.1 Analyst's Opinion Consensus RatingDoximity has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 3 buy ratings, 11 hold ratings, and 1 sell rating.Amount of Analyst CoverageDoximity has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Doximity's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 0.0 Dividend Strength Dividend YieldDoximity does not currently pay a dividend.Dividend GrowthDoximity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 2.3 News and Social Media Coverage News SentimentDoximity has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 21 news articles for Doximity this week, compared to 6 articles on an average week.Search Interest25 people have searched for DOCS on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $171,250.00 in company stock.Percentage Held by Insiders39.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Doximity's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Doximity are expected to grow by 10.81% in the coming year, from $0.74 to $0.82 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Doximity is 41.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 132.44.Price to Earnings Ratio vs. SectorThe P/E ratio of Doximity is 41.08, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 115.38.Price to Earnings Growth RatioDoximity has a PEG Ratio of 5.54. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDoximity has a P/B Ratio of 6.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Doximity's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe Key to this $10 Trillion Tech BoomPresident Biden has just approved $2.6 billion for this breakthrough technology… And it has nothing to do with artificial intelligence, cryptocurrency, or the blockchain.To get all the details of this new tech – click here now. About Doximity Stock (NASDAQ:DOCS)Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Read More DOCS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesMay 28, 2024 | marketbeat.comDoximity is the Facebook and LinkedIn of the Medical CommunityDoximity stock is surging as analysts and investors are taking note of the cloud-based digital platform's strong revenue and earnings growthMay 22, 2024 | marketbeat.comDoximity is the Facebook and LinkedIn of the Medical CommunityDoximity Inc. NASDAQ: DOCS is a social networking platform exclusively designed for U.S. healthcare professionals. It's a cross between Meta Platforms Inc. NASDAQ: META owned Facebook and Microsoft Co. NASDAQ: MSFT owned LinkedIn.May 18, 2024 | insidertrades.comDoximity, Inc. (NASDAQ:DOCS) Insider Craig Overpeck Sells 1,500 SharesJune 14 at 9:30 AM | globenewswire.comDOCS Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Doximity, Inc. (DOCS) Investors of Filing Deadline in Class Action LawsuitJune 13 at 11:00 AM | prnewswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitJune 13 at 10:41 AM | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. – DOCSJune 13 at 10:20 AM | businesswire.comDOCS Investors Have Opportunity to Join Doximity, Inc. Securities Fraud Investigation with the Schall Law FirmJune 13 at 2:14 AM | americanbankingnews.comBrokerages Set Doximity, Inc. (NASDAQ:DOCS) Price Target at $28.73June 12 at 10:28 PM | globenewswire.comDOXIMITY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCSJune 12 at 8:52 PM | businesswire.comRosen Law Firm Urges Doximity, Inc. (DOCS) Stockholders with Large Losses to Contact the Firm for Information About Their RightsJune 12 at 12:00 PM | prnewswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitJune 12 at 10:50 AM | globenewswire.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoximityJune 12 at 4:00 AM | globenewswire.comDOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!June 11 at 10:35 PM | globenewswire.comDOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCSJune 11 at 11:35 AM | globenewswire.comDoximity, Inc. Investors Notice: Class action lawsuit filed on behalf of investors; the Portnoy Law FirmJune 10, 2024 | prnewswire.comDeadline in 7 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Doximity, Inc. (DOCS)June 10, 2024 | globenewswire.comDOXIMITY, INC. (NYSE: DOCS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Doximity, Inc.June 9, 2024 | globenewswire.comDeadline in 8 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Doximity, Inc. (DOCS)June 8, 2024 | businesswire.comDeadline in 9 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Doximity, Inc. (DOCS)June 7, 2024 | prnewswire.comDOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCSJune 6, 2024 | prnewswire.comDOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud LawsuitJune 6, 2024 | businesswire.comDOCS INVESTOR ALERT: Kirby McInerney LLP Notifies Doximity, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitJune 6, 2024 | prnewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DoximityJune 5, 2024 | globenewswire.comDOXIMITY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCSJune 5, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. – DOCSSee More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2024Today6/14/2024Next Earnings (Estimated)8/13/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Custom computer programming services Sub-IndustryN/A Current SymbolNASDAQ:DOCS CUSIPN/A CIK1516513 Webwww.doximity.com Phone650-549-4330FaxN/AEmployees977Year FoundedN/APrice Target and Rating Average Stock Price Target$28.73 High Stock Price Target$33.00 Low Stock Price Target$23.00 Potential Upside/Downside-2.9%Consensus RatingHold Rating Score (0-4)2.13 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$0.72 Trailing P/E Ratio41.11 Forward P/E Ratio40.00 P/E Growth5.54Net Income$147.58 million Net Margins31.04% Pretax Margin38.96% Return on Equity17.44% Return on Assets14.85% Debt Debt-to-Equity RatioN/A Current Ratio6.20 Quick Ratio6.20 Sales & Book Value Annual Sales$475.42 million Price / Sales11.55 Cash Flow$0.92 per share Price / Cash Flow32.15 Book Value$4.83 per share Price / Book6.13Miscellaneous Outstanding Shares185,430,000Free Float112,368,000Market Cap$5.49 billion OptionableNot Optionable Beta1.23 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Jeffrey A. Tangney (Age 51)Co-Founder, CEO & Chairperson Comp: $243.73kDr. Nate Gross M.D. (Age 40)Co-Founder & Chief Strategy Officer Comp: $455.54kMs. Anna Bryson (Age 34)Chief Financial Officer Comp: $453.71kMs. Jennifer W. Chaloemtiarana (Age 56)General Counsel & Corporate Secretary Comp: $504.04kMr. Paul Jorgensen (Age 53)Chief Revenue Officer Comp: $455.13kMs. Shari BuckCo-founder and SVP People & OpsMr. Jey BalachandranChief Technology OfficerMr. Perry Scott GoldHead of Investor RelationsJim RivasHead of Corporate CommunicationsMr. Bruno MirandaSenior VP of EngineeringMore ExecutivesKey CompetitorsPegasystemsNASDAQ:PEGASmartsheetNYSE:SMARFive9NASDAQ:FIVNAvalaraNYSE:AVLRRealPageNASDAQ:RPView All CompetitorsInsiders & InstitutionsDekaBank Deutsche GirozentraleBought 1,695 shares on 6/4/2024Ownership: 0.001%Swedbank ABBought 3,406,670 shares on 5/21/2024Ownership: 1.826%LRI Investments LLCBought 1,000 shares on 5/21/2024Ownership: 0.001%Virtu Financial LLCBought 8,295 shares on 5/20/2024Ownership: 0.004%Comerica BankBought 2,480 shares on 5/17/2024Ownership: 0.034%View All Insider TransactionsView All Institutional Transactions DOCS Stock Analysis - Frequently Asked Questions Should I buy or sell Doximity stock right now? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last twelve months. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares. View DOCS analyst ratings or view top-rated stocks. What is Doximity's stock price target for 2024? 15 brokerages have issued 12 month target prices for Doximity's stock. Their DOCS share price targets range from $23.00 to $33.00. On average, they expect the company's share price to reach $28.73 in the next year. This suggests that the stock has a possible downside of 2.9%. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2024? Doximity's stock was trading at $28.04 on January 1st, 2024. Since then, DOCS stock has increased by 5.5% and is now trading at $29.58. View the best growth stocks for 2024 here. When is Doximity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our DOCS earnings forecast. How were Doximity's earnings last quarter? Doximity, Inc. (NASDAQ:DOCS) released its quarterly earnings results on Thursday, May, 16th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.16 by $0.04. The firm had revenue of $118.06 million for the quarter, compared to analysts' expectations of $116.46 million. Doximity had a net margin of 31.04% and a trailing twelve-month return on equity of 17.44%. What ETFs hold Doximity's stock? ETFs with the largest weight of Doximity (NASDAQ:DOCS) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Jacob Forward ETF (JFWD), Janus Henderson Small Cap Growth Alpha ETF (JSML), Fidelity Digital Health ETF (FDHT), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Renaissance IPO ETF (IPO), SPDR FactSet Innovative Technology ETF (XITK) and Pacer US Large Cap Cash Cows Growth Leaders ETF (COWG). What guidance has Doximity issued on next quarter's earnings? Doximity issued an update on its first quarter 2025 earnings guidance on Thursday, May, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $119.5 million-$120.5 million, compared to the consensus revenue estimate of $119.2 million. When did Doximity IPO? Doximity (DOCS) raised $501 million in an initial public offering on Thursday, June 24th 2021. The company issued 23,300,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers. Who are Doximity's major shareholders? Doximity's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.77%), Baillie Gifford & Co. (3.33%), William Blair Investment Management LLC (2.96%), Clearbridge Investments LLC (2.93%), Swedbank AB (1.83%) and Janus Henderson Group PLC (1.33%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Doximity? Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DOCS) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Doximity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Doximity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.